<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-JH8LYJIO/f09c4e95-e934-4a34-805a-eec640e387d3/HTML"><dcterms:extent>39 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-JH8LYJIO/6f8bcbfd-f301-4c2c-93a3-9aba41d42d09/PDF"><dcterms:extent>95 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-JH8LYJIO/93728133-54f3-41ab-ba22-a0c4a4fcfa25/TEXT"><dcterms:extent>24 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1929-2026"><edm:begin xml:lang="en">1929</edm:begin><edm:end xml:lang="en">2026</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:DOC-JH8LYJIO"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/urn:nbn:si:spr-a30mfzkp" /><dcterms:issued>2008</dcterms:issued><dc:creator>Ećimović, Patricija</dc:creator><dc:creator>Janež, Andrej</dc:creator><dc:creator>Rotovnik-Kozjek, Nada</dc:creator><dc:format xml:lang="sl">številka:3</dc:format><dc:format xml:lang="sl">5 strani</dc:format><dc:format xml:lang="sl">letnik:77</dc:format><dc:format xml:lang="sl">str. 219-223</dc:format><dc:identifier>ISSN:1318-0347</dc:identifier><dc:identifier>COBISSID:24201945</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-JH8LYJIO</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Slovensko zdravniško društvo</dc:publisher><dcterms:isPartOf xml:lang="sl">Zdravniški vestnik</dcterms:isPartOf><dc:subject xml:lang="en">Cachexia</dc:subject><dc:subject xml:lang="en">diagnostika</dc:subject><dc:subject xml:lang="en">Etiology</dc:subject><dc:subject xml:lang="sl">Hipoglikemija</dc:subject><dc:subject xml:lang="en">Hypoglycemia</dc:subject><dc:subject xml:lang="en">Insulin-Like Growth Factor Ii</dc:subject><dc:subject xml:lang="sl">Insulinoma</dc:subject><dc:subject xml:lang="sl">Inzulinom</dc:subject><dc:subject xml:lang="sl">Inzulin-podobn, rastni faktor II</dc:subject><dc:subject xml:lang="sl">Jetra, novotvorbe</dc:subject><dc:subject xml:lang="sl">Kaheksija</dc:subject><dc:subject xml:lang="en">Liver Neoplasms</dc:subject><dc:subject xml:lang="en">Neoplasms</dc:subject><dc:subject xml:lang="sl">Novotvorbe</dc:subject><dc:subject xml:lang="sl">onkologija</dc:subject><dc:subject xml:lang="en">Paraneoplastic Syndromes</dc:subject><dc:subject xml:lang="sl">Paraneoplastični sindromi</dc:subject><dc:subject xml:lang="en">Secondary</dc:subject><dc:subject xml:lang="en">tumor</dc:subject><dc:subject xml:lang="sl">tumorska hipoglikemija</dc:subject><dcterms:temporal rdf:resource="1929-2026" /><dc:title xml:lang="sl">Tumorska hipoglikemija - premalo prepoznano nujno stanje| Tumor hypoglycemia - under-recognized medical emergency|</dc:title><dc:description xml:lang="sl">Background Tumor hypoglycemia is a rare and easily misdiagnosed non-diabetic hypoglycemia that newly arises in a cancer patient. Itćs resistant to symptomatic treatment so it is important to investigate for its causes to treat it successfully. Tumor hypoglycemia can be caused by insulinoma, by tumor secretion of insulin-like substances (Insuline-like growth factor 2, IGF-2), liver metastases, cachexia or paraneoplastic endocrine abnormalities. Conclusions We are presenting a review of current literature on tumor hypoglycemia that highlights the importance of investigating causative mechanisms in order to control it</dc:description><dc:description xml:lang="sl">Izhodišča Tumorska hipoglikemija je redka in zato pogosto spregledana oblika hipoglikemije, ki se na novo pojavi pri bolnikih z rakom. Se ponavlja in je odporna na simptomatsko zdravljenje. Povzročajo jo nevroendokrini tumorji, kotje inzulinom, tumorsko izločanje inzulinu podobne beljakovine (Insuline-like growth factor 2, IGF-2), jetrne metastaze, kaheksija ali pridružene endokrine motnje. Zaključki Za uspešno usmerjeno zdravljenje je ključno prepoznavanje vzroka tumorske hipoglikemije, sicer se hipoglikemične epizode ponavljajo in resno ogrožajo bolnikovo življenje. Predstaviti želimo pregled literature o prepoznavanju in zdravljenju tumorske hipoglikemije</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:DOC-JH8LYJIO"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:DOC-JH8LYJIO" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:DOC-JH8LYJIO/6f8bcbfd-f301-4c2c-93a3-9aba41d42d09/PDF" /><edm:rights rdf:resource="http://creativecommons.org/licenses/by-nc/4.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Slovensko zdravniško društvo</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:DOC-JH8LYJIO/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:DOC-JH8LYJIO" /></ore:Aggregation></rdf:RDF>